{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:50:33Z","timestamp":1788403833178,"version":"build-2803163510"},"reference-count":3,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T00:00:00Z","timestamp":1448236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contact Dermatitis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1111\/cod.12476","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T20:37:08Z","timestamp":1450730228000},"page":"366-367","source":"Crossref","is-referenced-by-count":12,"title":["Allergic contact dermatitis caused by Mirvaso\u00ae, brimonidine tartrate gel 0.33%, a new topical treatment for rosaceal erythema"],"prefix":"10.1111","volume":"73","author":[{"given":"Hannah","family":"Cookson","sequence":"first","affiliation":[{"name":"Department of Cutaneous Allergy St John's Institute of Dermatology, Guy's & St. Thomas' Hospitals  London SE1 9RT UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McFadden","sequence":"additional","affiliation":[{"name":"Department of Cutaneous Allergy St John's Institute of Dermatology, Guy's & St. Thomas' Hospitals  London SE1 9RT UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"White","sequence":"additional","affiliation":[{"name":"Department of Cutaneous Allergy St John's Institute of Dermatology, Guy's & St. Thomas' Hospitals  London SE1 9RT UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"White","sequence":"additional","affiliation":[{"name":"Department of Cutaneous Allergy St John's Institute of Dermatology, Guy's & St. Thomas' Hospitals  London SE1 9RT UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,11,23]]},"reference":[{"key":"e_1_2_4_2_1","first-page":"56","article-title":"Long\u2010term safety and efficacy of once\u2010daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1\u2010year open\u2010label study","volume":"13","author":"Moore A","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_4_3_1","unstructured":"Anonymous.2015. Available at:http:\/\/www.allergan.com\/assets\/pdf\/alphaganp_pi.pdf."},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.05.073"}],"container-title":["Contact Dermatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcod.12476","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcod.12476","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cod.12476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T14:07:52Z","timestamp":1695478072000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cod.12476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,23]]},"references-count":3,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1111\/cod.12476"],"URL":"https:\/\/doi.org\/10.1111\/cod.12476","archive":["Portico"],"relation":{},"ISSN":["0105-1873","1600-0536"],"issn-type":[{"value":"0105-1873","type":"print"},{"value":"1600-0536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,23]]}}}